To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene XPNPEP3andRBX1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
472 representative clones for gene XPNPEP3andRBX1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_022098.2   .a 1 to 3060 1 to 3060 exact RefSeq,   3060/3060
(100 %)
0 diff
(100 %id)
AL365514   .a 9 to 2773 1 to 2765 exact tiling clone,   2765/2765
(100 %)
0 diff
(100 %id)
BC001681 Lung, small cell carcinoma .a 25 to 1735 1 to 1711 L486F available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1711/1711
(100 %)
1 diff
(100.0 %id)
BC004989 Lung, small cell carcinoma .a 25 to 1735 1 to 1711 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1711/1711
(100 %)
0 diff
(100 %id)
BE206978 lung, small cell carcinoma .a 26 to 665 1 to 640     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 640/640
(100 %)
9 diff
(98.6 %id)
AK313770 testis .a 31 to 1616 1 to 1586 exact     1586/1586
(100 %)
0 diff
(100 %id)
DN995399 breast cancer, Mammary gland (cancer tissue) .a 31 to 627 1 to 597       597/597
(100 %)
7 diff
(98.9 %id)
DB036063 testis .a 32 to 584 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AU280088   .a 38 to 571 1 to 534       534/536
(99 %)
1 diff
(99.9 %id)
CR456442   .a 56 to 1669 1 to 1614 exact     1614/1614
(100 %)
0 diff
(100 %id)
BF312694 brain, neuroblastoma .a 56 to 536 1 to 483       483/485
(99 %)
9 diff
(98.2 %id)
BF315687 brain, neuroblastoma .a 56 to 754 1 to 693       693/891
(77 %)
10 diff
(98.9 %id)
BI199865 brain, neuroblastoma .a 56 to 884 1 to 827       827/1050
(78 %)
27 diff
(97.5 %id)
DB028060 testis .a 66 to 599 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DB270543 uterus .a 66 to 607 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
TI_57197119   .a 68 to 883 20 to 837       818/874
(93 %)
20 diff
(97.8 %id)
BE261625 brain, neuroblastoma .a 76 to 558 1 to 483       483/485
(99 %)
1 diff
(99.8 %id)
BI820933 pooled brain, lung, testis .a 78 to 883 1 to 808       808/845
(95 %)
16 diff
(98.2 %id)
CD631181   .a 80 to 196 8 to 124       117/125
(93 %)
7 diff
(94.4 %id)
CD631182   .a 80 to 194 115 to 1       115/122
(94 %)
0 diff
(100 %id)
CD631183   .a 80 to 196 8 to 124       117/125
(93 %)
7 diff
(94.4 %id)
CD631184   .a 80 to 194 114 to 1       114/121
(94 %)
1 diff
(99.2 %id)
CD631185   .a 80 to 196 8 to 123       116/124
(93 %)
8 diff
(93.6 %id)
CD631186   .a 80 to 194 116 to 1       116/123
(94 %)
2 diff
(98.4 %id)
CD631189   .a 80 to 196 8 to 124       117/125
(93 %)
7 diff
(94.4 %id)
CD631190   .a 80 to 192 112 to 1       112/119
(94 %)
1 diff
(99.2 %id)
TI_57174719   .a 82 to 758 36 to 717       682/717
(95 %)
17 diff
(97.7 %id)
BI827371 brain, medulla .a 83 to 758 1 to 682       682/682
(100 %)
14 diff
(98.0 %id)
CD631187   .a 90 to 196 1 to 107       107/108
(99 %)
3 diff
(97.3 %id)
CD631188   .a 90 to 196 107 to 1       107/107
(100 %)
1 diff
(99.1 %id)
CR457396   .a 93 to 1614 1 to 1522       1522/1524
(99 %)
2 diff
(99.9 %id)
CV026606 mixed .a 93 to 669 1 to 577       577/577
(100 %)
8 diff
(98.7 %id)
CU013328 Synthetic constructs .a 93 to 1620 20 to 1547 exact     1528/1555
(98 %)
14 diff
(99.1 %id)
CU013040 Synthetic constructs .a 93 to 1618 20 to 1545 exact     1526/1558
(97 %)
7 diff
(99.6 %id)
TI_1948080916   .a 93 to 878 127 to 913   fully sequenced,   787/913
(86 %)
16 diff
(98.3 %id)
TI_1948081095   .a 93 to 885 131 to 924       794/1311
(60 %)
17 diff
(98.8 %id)
TI_1948081270   .a 93 to 879 130 to 916       787/1257
(62 %)
11 diff
(99.2 %id)
TI_1948081447   .a 93 to 840 133 to 880   fully sequenced,   748/880
(85 %)
8 diff
(99.1 %id)
DW461981 Liver .a 127 to 236 12 to 121       110/121
(90 %)
6 diff
(95.1 %id)
TI_1948081448   .a 810 to 1618 939 to 120   fully sequenced,   820/939
(87 %)
16 diff
(98.3 %id)
TI_1948080917   .a 847 to 1618 894 to 120   fully sequenced,   775/894
(86 %)
5 diff
(99.5 %id)
TI_1948081271   .a 882 to 1618 855 to 117       739/1282
(57 %)
2 diff
(99.9 %id)
TI_1948081096   .a 887 to 1618 854 to 120       735/1452
(50 %)
10 diff
(99.4 %id)
CD359071 testis .a 1000 to 1832 1 to 840       840/872
(96 %)
8 diff
(99.1 %id)
BX099353 liver and spleen .a 1194 to 1928 737 to 1     Submitted on the opposite strand 737/737
(100 %)
2 diff
(99.8 %id)
AW732081 lung, small cell carcinoma .a 1356 to 1735 400 to 21   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 380/380
(100 %)
3 diff
(99.3 %id)
AI479803 anaplastic oligodendroglioma, brain .a 1474 to 2123 656 to 7       650/660
(98 %)
0 diff
(100 %id)
BE877442 large cell carcinoma, undifferentiated, lung .a 1492 to 2141 1 to 648       648/871
(74 %)
8 diff
(99.1 %id)
AA382300 testis .a 1494 to 1735 1 to 242       242/242
(100 %)
0 diff
(100 %id)
CX752771 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1514 to 2300 1 to 781     Submitted on the opposite strand 781/784
(99 %)
14 diff
(98.3 %id)
EC539254 Prostate .a 1631 to 1715 1 to 85       85/85
(100 %)
0 diff
(100 %id)
AA700729 liver and spleen .a 1858 to 2326 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AA699699 liver and spleen .a 1897 to 2326 430 to 1       430/430
(100 %)
0 diff
(100 %id)
R85448 liver and spleen .a 1950 to 2319 377 to 3       375/377
(99 %)
0 diff
(100 %id)
EC546488 Prostate .a 1960 to 2059 16 to 113       98/113
(86 %)
6 diff
(94.7 %id)
EC529688 Prostate .a 2207 to 2314 1 to 107       107/107
(100 %)
5 diff
(95.4 %id)
AI619443 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2253 to 2683 443 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 431/431
(100 %)
11 diff
(97.5 %id)
AI623350 adenocarcinoma, Pancreas .a 2257 to 2686 430 to 1       430/430
(100 %)
16 diff
(96.3 %id)
AI292218 carcinoid, lung .a 2293 to 2747 455 to 1       455/455
(100 %)
14 diff
(97.0 %id)
BU631357 cell lines, Chondrosarcoma .a 2362 to 3073 713 to 1   tiling clone,   713/713
(100 %)
6 diff
(99.2 %id)
AI446638 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2662 to 3060 399 to 1   tiling clone,   399/399
(100 %)
0 diff
(100 %id)
AI311557 2 pooled tumors (clear cell type), Kidney .a 2665 to 3067 403 to 1       403/403
(100 %)
13 diff
(96.8 %id)
DB022029 testis .b 1 to 555 2 to 559   tiling clone, capped   558/563
(99 %)
5 diff
(99.2 %id)
AK301758 testis .b 23 to 2271 1 to 2249 exact tiling clone,   2249/2249
(100 %)
1 diff
(100.0 %id)
DB023743 testis .b 24 to 543 2 to 522   capped   521/521
(100 %)
1 diff
(99.9 %id)
CD654136 Embryonic Stem cells .b 555 to 1226 1 to 670       670/717
(93 %)
9 diff
(98.8 %id)
BU186825 large cell carcinoma, lung .b 1028 to 1480 1 to 460       460/727
(63 %)
9 diff
(98.8 %id)
CD558137 testis .b 1281 to 1610 1 to 332       332/886
(37 %)
3 diff
(99.7 %id)
DB336029 testis .b 1328 to 1876 549 to 1       549/549
(100 %)
0 diff
(100 %id)
FN077010 breast carcinoma .b 2166 to 2235 1 to 69       69/71
(97 %)
2 diff
(97.2 %id)
DA238175 brain .c 1 to 534 2 to 536   tiling clone, capped   535/535
(100 %)
1 diff
(99.9 %id)
AL834310 testis .c 30 to 2765 1 to 2736 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2736/2736
(100 %)
0 diff
(100 %id)
TI_57170195   .d 1 to 684 30 to 713   tiling clone,   684/713
(95 %)
7 diff
(99.1 %id)
BI825148 brain, medulla .d 9 to 684 1 to 675   tiling clone,   675/675
(100 %)
1 diff
(99.9 %id)
BE788822 large cell carcinoma, lung .d 640 to 1272 1 to 631   tiling clone,   631/631
(100 %)
4 diff
(99.4 %id)
AK301635 esophagus, tumor tissue .e 1 to 1042 3 to 1044 exact tiling clone,   1044/1044
(100 %)
2 diff
(99.9 %id)
DC393781 esophageal, tumor tissue .e 1 to 562 3 to 564       564/564
(100 %)
2 diff
(99.7 %id)
DB251140 uterus .e 1 to 508 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
CN484448 eye .e 12 to 630 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
DA912613   .e 16 to 579 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BC001208 Brain, neuroblastoma .f 1 to 1084 4 to 1087 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1087/1087
(100 %)
1 diff
(100.0 %id)
BI260841 cervical carcinoma cell line, cervix .g 1 to 805 1 to 806 E62R V63* tiling clone,   806/807
(99 %)
13 diff
(98.4 %id)
DW416315 Liver .g 582 to 881 10 to 309   tiling clone,   300/309
(97 %)
12 diff
(96.2 %id)
AA703314 liver and spleen .g 638 to 1114 476 to 1   tiling clone,   476/476
(100 %)
6 diff
(98.8 %id)
AK310502 testis .h 1 to 1441 1 to 1441 exact tiling clone,   1441/1441
(100 %)
0 diff
(100 %id)
DB093050 testis .h 2 to 551 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DB024681 testis .h 8 to 565 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BI832228 brain, medulla .h 10 to 695 10 to 697       688/698
(98 %)
9 diff
(98.8 %id)
TI_57175980   .h 10 to 695 10 to 697       688/698
(98 %)
9 diff
(98.8 %id)
BM800729 melanotic melanoma, skin .i-u 1 to 839 23 to 862 exact tiling clone, available from MGC,   840/1024
(82 %)
15 diff
(98.6 %id)
BC037424 Skin, melanotic melanoma. .i-u 2 to 936 1 to 935 exact tiling clone, available from MGC, AAA   935/935
(100 %)
0 diff
(100 %id)
DB477602 hippocampus .i-u 9 to 503 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
AV737639 cord Blood .i-u 17 to 553 43 to 578       536/614
(87 %)
18 diff
(97.1 %id)
BX119041   .i-u 18 to 409 1 to 392       392/392
(100 %)
0 diff
(100 %id)
BE617460 adenocarcinoma, colon .i-u 97 to 913 1 to 806       806/888
(90 %)
36 diff
(96.0 %id)
BE617907 adenocarcinoma, colon .i-u 101 to 889 791 to 1       791/791
(100 %)
4 diff
(99.5 %id)
BM466568 eye, retinoblastoma .i-u 139 to 937 19 to 825       807/938
(86 %)
18 diff
(98.1 %id)
CA314208 Human Lung Epithelial cells, lung .i-u 243 to 936 708 to 19   AAA   690/690
(100 %)
5 diff
(99.3 %id)
CB409178 maxilla, pooled .i-u 334 to 924 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
CB409437 maxilla, pooled .i-u 334 to 915 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BQ380466 uterus_tumor .i-u 337 to 752 1 to 417       417/417
(100 %)
4 diff
(99.1 %id)
BE940681 uterus_tumor .i-u 341 to 791 13 to 459       447/460
(97 %)
12 diff
(97.4 %id)
BE674036 carcinoid, lung .i-u 346 to 937 596 to 5       592/596
(99 %)
0 diff
(100 %id)
BQ380465 uterus_tumor .i-u 383 to 731 360 to 16       345/360
(95 %)
0 diff
(100 %id)
AA775784 whole brain .i-u 399 to 937 542 to 1       542/542
(100 %)
31 diff
(94.3 %id)
AW005574 anaplastic oligodendroglioma, brain .i-u 412 to 937 527 to 2       526/527
(99 %)
0 diff
(100 %id)
AI885037 anaplastic oligodendroglioma, brain .i-u 434 to 935 517 to 16   AAA   502/502
(100 %)
1 diff
(99.9 %id)
AI127653 uterus .i-u 462 to 942 480 to 2       479/480
(99 %)
0 diff
(100 %id)
AI471784 Kidney .i-u 467 to 936 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AW002166 thymus, pooled .i-u 531 to 937 411 to 4       408/411
(99 %)
0 diff
(100 %id)
AI652199 pooled germ cell tumors .i-u 543 to 936 394 to 1       394/396
(99 %)
1 diff
(99.8 %id)
AA398384   .i-u 550 to 935 389 to 4       386/389
(99 %)
0 diff
(100 %id)
DB546196 hippocampus .i-u 608 to 936 1 to 329     Submitted on the opposite strand 329/329
(100 %)
2 diff
(99.4 %id)
AW593748 pooled germ cell tumors .i-u 675 to 936 262 to 1       262/262
(100 %)
0 diff
(100 %id)
C21259   .i-u 758 to 940 1 to 183       183/183
(100 %)
0 diff
(100 %id)
BP346902 brain .j 1 to 575 8 to 582 exact tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
CN257899 embryonic stem cells, DMSO-treated H9 cellline .k -8 to 451 1 to 460 exact tiling clone,   460/460
(100 %)
0 diff
(100 %id)
BG497476 adenocarcinoma, Prostate .k 36 to 671 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
CN257897 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 82 to 805 1 to 724   tiling clone,   724/724
(100 %)
1 diff
(99.9 %id)
N23017 melanocyte .l 1 to 490 495 to 2 N16K A17C V18Q A19V L20X ... tiling clone,   492/495
(99 %)
13 diff
(97.4 %id)
FN086918 breast carcinoma .m 1 to 90 89 to 1   tiling clone, Submitted on the opposite strand 89/89
(100 %)
2 diff
(97.8 %id)
BU533420 mixed (pool of 40 RNAs) .m 23 to 568 1 to 546 exact     546/551
(99 %)
3 diff
(99.5 %id)
BG339057 leiomyosarcoma cell line, uterus .m 25 to 476 1 to 452 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 452/452
(100 %)
1 diff
(99.8 %id)
BU533405 mixed (pool of 40 RNAs) .m 29 to 566 1 to 538 exact     538/539
(99 %)
2 diff
(99.7 %id)
BU597842 mixed (pool of 40 RNAs) .m 35 to 568 1 to 534 exact     534/570
(93 %)
7 diff
(98.8 %id)
BU861191 mixed (pool of 40 RNAs) .m 35 to 564 1 to 530 exact     530/563
(94 %)
2 diff
(99.7 %id)
BU941262 mixed (pool of 40 RNAs) .m 35 to 549 1 to 515 exact     515/545
(94 %)
2 diff
(99.7 %id)
CD051073 embryonic trophoblasts, made from WA01 stemcells .m 38 to 566 23 to 550 A3V AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 528/550
(96 %)
6 diff
(99.0 %id)
BU958173 mixed (pool of 40 RNAs) .m 38 to 568 1 to 531 A43S     531/564
(94 %)
6 diff
(99.0 %id)
CD172680 embryonic stem cells, WA01, passage 38 .m 39 to 566 18 to 544 A2R A3F A4R M5W D6M ... AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 527/544
(96 %)
6 diff
(98.9 %id)
DA528969 brain .m 39 to 633 2 to 596 exact tiling clone, capped   595/595
(100 %)
0 diff
(100 %id)
CD249363 embryonic stem cells, WA01, passage 38 .m 40 to 565 10 to 533 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 524/533
(98 %)
7 diff
(98.7 %id)
BF956282 nervous_normal .m 41 to 445 1 to 405 exact     405/405
(100 %)
4 diff
(99.1 %id)
BU858782 mixed (pool of 40 RNAs) .m 42 to 568 1 to 527 I44L     527/557
(94 %)
6 diff
(99.0 %id)
CB999822 Pooled-Skin .m 42 to 564 1 to 523 exact     523/527
(99 %)
3 diff
(99.5 %id)
CN305890 embryonic stem cells, DMSO-treated H9 cellline .m 43 to 504 1 to 462 exact     462/462
(100 %)
5 diff
(99.0 %id)
BU932751 mixed (pool of 40 RNAs) .m 43 to 567 1 to 525 exact     525/527
(99 %)
4 diff
(99.3 %id)
BG534675 lung .m 44 to 568 1 to 526 N98S     526/653
(80 %)
6 diff
(99.1 %id)
BG777485 adenocarcinoma, Prostate .m 44 to 529 1 to 487 exact     487/488
(99 %)
4 diff
(99.2 %id)
CB857843 anterior tongue, pooled .m 44 to 521 1 to 478 exact     478/478
(100 %)
3 diff
(99.4 %id)
CD523457 pooled .m 44 to 567 1 to 525 exact     525/531
(98 %)
5 diff
(99.1 %id)
CK003869 brain/CNS, Human Brain - Cerebellar Cortex .m 44 to 564 1 to 521 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 521/521
(100 %)
3 diff
(99.5 %id)
CD388268 embryonic trophoblasts, made from WA01 stemcells .m 45 to 571 12 to 537 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 526/537
(97 %)
6 diff
(98.9 %id)
CF124625 CNCAP(3)T-225 cell line, Prostate .m 45 to 566 38 to 559 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 522/559
(93 %)
7 diff
(98.8 %id)
BU601080 mixed (pool of 40 RNAs) .m 45 to 568 1 to 524 exact     524/555
(94 %)
3 diff
(99.5 %id)
BU954591 mixed (pool of 40 RNAs) .m 45 to 565 1 to 521 exact     521/523
(99 %)
4 diff
(99.3 %id)
TI_154184975   .m 45 to 566 107 to 628 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 522/552
(94 %)
7 diff
(98.8 %id)
AV715190   .m 46 to 566 1 to 521 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 521/521
(100 %)
3 diff
(99.5 %id)
BU594675 mixed (pool of 40 RNAs) .m 46 to 568 1 to 523 exact     523/527
(99 %)
4 diff
(99.3 %id)
BF679205 Prostate .m 47 to 565 1 to 512 I37M V38W V39L D40I N41T ... AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 512/512
(100 %)
9 diff
(98.3 %id)
BG531117 embryonal carcinoma, testis .m 47 to 450 1 to 403 exact     403/403
(100 %)
8 diff
(98.1 %id)
BM757406 Ascites, stomach .m 47 to 562 14 to 529 exact     516/516
(100 %)
0 diff
(100 %id)
CD175085 embryonic stem cells, WA01, passage 38 .m 48 to 566 23 to 540 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 518/540
(95 %)
7 diff
(98.8 %id)
CR456560   .m 48 to 582 1 to 535 exact     535/535
(100 %)
0 diff
(100 %id)
DW411008 Liver .m 48 to 361 18 to 331       314/331
(94 %)
6 diff
(98.2 %id)
BC017370 Brain, glioblastoma .m 48 to 567 5 to 524 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 520/521
(99 %)
2 diff
(99.7 %id)
BG478622 melanotic melanoma, skin .m 48 to 565 1 to 518 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
BG705958 brain, hypothalamus .m 48 to 566 1 to 519 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 519/519
(100 %)
4 diff
(99.3 %id)
CB121873 Liver .m 48 to 289 1 to 242       242/242
(100 %)
1 diff
(99.6 %id)
NM_014248.2   .m 48 to 568 1 to 521 exact RefSeq,   521/521
(100 %)
0 diff
(100 %id)
BI198015 brain, neuroblastoma .m 49 to 568 1 to 527 exact     527/546
(96 %)
8 diff
(98.6 %id)
BU601301 mixed (pool of 40 RNAs) .m 50 to 568 1 to 519 exact     519/521
(99 %)
5 diff
(99.1 %id)
BU955646 mixed (pool of 40 RNAs) .m 50 to 565 1 to 516 exact     516/517
(99 %)
4 diff
(99.3 %id)
DT220847 brain .m 53 to 791 1 to 738 exact     738/738
(100 %)
1 diff
(99.9 %id)
DB475306 hippocampus .m 53 to 528 1 to 476 exact     476/476
(100 %)
0 diff
(100 %id)
CB137618 Liver .m 53 to 565 1 to 512 H82R AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 512/512
(100 %)
5 diff
(99.1 %id)
BP308845 brain .m 53 to 565 1 to 513 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
DA003707   .m 54 to 627 2 to 576 D8G V70C A71R W72M V74S ... capped   575/575
(100 %)
2 diff
(99.7 %id)
DA466653 cord Blood .m 54 to 566 2 to 515 exact capped   514/524
(98 %)
2 diff
(99.7 %id)
BU601181 mixed (pool of 40 RNAs) .m 54 to 566 1 to 513 exact     513/513
(100 %)
4 diff
(99.3 %id)
BU532840 mixed (pool of 40 RNAs) .m 54 to 571 1 to 518 exact     518/527
(98 %)
3 diff
(99.5 %id)
AK315722 testis .m 55 to 392 1 to 338 exact     338/338
(100 %)
0 diff
(100 %id)
AL711573 human skeletal muscle .m 55 to 567 10 to 522 exact     513/513
(100 %)
0 diff
(100 %id)
BP317451 pericardium .m 55 to 566 1 to 513 exact     513/521
(98 %)
4 diff
(99.3 %id)
DA150258 amygdala .m 56 to 290 2 to 236   capped   235/235
(100 %)
1 diff
(99.6 %id)
DB493781 hypothalamus .m 56 to 562 1 to 507 D8G     507/507
(100 %)
3 diff
(99.5 %id)
DB493801 hypothalamus .m 56 to 546 1 to 491 D8G     491/497
(98 %)
4 diff
(99.2 %id)
DB501198 hypothalamus .m 56 to 550 1 to 495 D8G     495/495
(100 %)
3 diff
(99.4 %id)
BM459634 leiomyosarcoma, uterus .m 56 to 954 1 to 899 exact tiling clone,   899/904
(99 %)
8 diff
(99.2 %id)
DB090580 testis .m 56 to 568 2 to 514 exact capped   513/519
(98 %)
1 diff
(99.9 %id)
BF821575 kidney_tumor .m 57 to 332 274 to 1     Submitted on the opposite strand 274/274
(100 %)
1 diff
(99.7 %id)
BE735168 choriocarcinoma, placenta .m 57 to 566 1 to 510 A4L AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 510/510
(100 %)
7 diff
(98.7 %id)
CU013448 Synthetic constructs .m 57 to 389 11 to 343       333/358
(93 %)
6 diff
(98.4 %id)
CU013160 Synthetic constructs .m 57 to 396 11 to 350 exact     340/361
(94 %)
12 diff
(96.7 %id)
BP316685 pericardium .m 59 to 566 1 to 508 V39D E66G R86C AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 508/508
(100 %)
9 diff
(98.3 %id)
AF140598   .m 60 to 566 1 to 508 exact     508/508
(100 %)
2 diff
(99.7 %id)
BX283972 choriocarcinoma, placenta .m 60 to 532 1 to 473 exact     473/473
(100 %)
1 diff
(99.8 %id)
CD673786 eye, lens .m 60 to 566 1 to 507 R46M V74A AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 507/507
(100 %)
4 diff
(99.3 %id)
BP420485 small intestine .m 60 to 568 8 to 516 exact   Submitted on the opposite strand 509/518
(98 %)
7 diff
(98.7 %id)
BG337472 leiomyosarcoma cell line, uterus .m 60 to 566 1 to 507 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 507/507
(100 %)
1 diff
(99.9 %id)
AA379991 skin .m 61 to 272 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
BC001466 Placenta, choriocarcinoma .m 61 to 566 1 to 506 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 506/506
(100 %)
0 diff
(100 %id)
CN305892 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 61 to 568 1 to 508 exact     508/509
(99 %)
7 diff
(98.7 %id)
D52876   .m 62 to 253 1 to 192   fully sequenced,   192/192
(100 %)
0 diff
(100 %id)
CD686718 normal nasopharynx .m 63 to 328 1 to 266       266/266
(100 %)
4 diff
(98.5 %id)
BU729963 eye, Retina Foveal and Macular .m 63 to 565 521 to 19 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 503/515
(97 %)
0 diff
(100 %id)
BM715215 eye, human retina .m 63 to 565 1 to 503 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
TI_153984959   .m 63 to 565 55 to 557 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
BE566728 bladder, carcinoma, cell line .m 64 to 554 1 to 489 K25N W27V N28E A29C V30S ...     487/803
(60 %)
20 diff
(97.6 %id)
BQ220259 melanotic melanoma, skin .m 64 to 568 1 to 505 N14T S15A G16A A17R G18A ...     505/509
(99 %)
3 diff
(99.5 %id)
AA345277 gall bladder .m 65 to 381 1 to 316       316/316
(100 %)
1 diff
(99.7 %id)
AF142059   .m 66 to 392 1 to 327 exact     327/327
(100 %)
0 diff
(100 %id)
BE737604 brain, glioblastoma .m 67 to 568 1 to 493       493/700
(70 %)
11 diff
(98.5 %id)
BE738587 brain, glioblastoma .m 67 to 514 448 to 1       448/448
(100 %)
5 diff
(98.9 %id)
AI750496 Bone, Hip .m 67 to 506 1 to 440       440/440
(100 %)
7 diff
(98.5 %id)
BM711445 eye, fetal eyes .m 67 to 553 1 to 487   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 487/487
(100 %)
4 diff
(99.2 %id)
BE728298 melanotic melanoma, skin .m 68 to 564 1 to 498       498/498
(100 %)
3 diff
(99.4 %id)
BF684301 leiomyosarcoma cell line, uterus .m 68 to 566 1 to 499   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 499/499
(100 %)
1 diff
(99.8 %id)
CN305893 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 69 to 566 1 to 498   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 498/498
(100 %)
0 diff
(100 %id)
CN305897 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 69 to 321 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BE298380 muscle, rhabdomyosarcoma .m 69 to 734 1 to 660       660/748
(88 %)
19 diff
(97.5 %id)
CN305889 embryonic stem cells, DMSO-treated H9 cellline .m 70 to 565 1 to 496       496/496
(100 %)
6 diff
(98.8 %id)
AV751916 Pituitary .m 70 to 566 20 to 516   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 497/516
(96 %)
6 diff
(98.9 %id)
CN305887 embryonic stem cells, DMSO-treated H9 cellline .m 72 to 568 1 to 497       497/503
(98 %)
5 diff
(99.1 %id)
BM045028 carcinoma, cell line, Prostate .m 72 to 894 1 to 826       826/826
(100 %)
5 diff
(99.4 %id)
BM808337 amelanotic melanoma, cell line, skin .m 72 to 566 1 to 495   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 495/495
(100 %)
0 diff
(100 %id)
BU957127 adenocarcinoma, cell line, breast .m 72 to 565 1 to 494       494/495
(99 %)
1 diff
(99.8 %id)
BU957594 adenocarcinoma, cell line, breast .m 72 to 567 1 to 496       496/500
(99 %)
1 diff
(99.8 %id)
AW365113 denis_drash .m 73 to 446 372 to 1       372/372
(100 %)
8 diff
(97.9 %id)
AW365115 denis_drash .m 73 to 437 369 to 7       363/369
(98 %)
4 diff
(99.0 %id)
BF348984 denis_drash .m 73 to 434 370 to 7       364/371
(98 %)
19 diff
(94.9 %id)
CN305888 embryonic stem cells, DMSO-treated H9 cellline .m 73 to 566 1 to 494   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
CB113476 Liver .m 74 to 184 1 to 111       111/111
(100 %)
0 diff
(100 %id)
CN305894 embryonic stem cells, DMSO-treated H9 cellline .m 75 to 565 1 to 491   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
BG830409 epithelioid carcinoma cell line, Pancreas .m 76 to 565 1 to 490   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 490/490
(100 %)
2 diff
(99.6 %id)
BQ670844 epidermoid carcinoma, cell line, salivary gland .m 76 to 566 1 to 491   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
BM697883 eye, fetal eyes .m 78 to 465 1 to 388   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AW365093 denis_drash .m 79 to 437 360 to 4       357/361
(98 %)
6 diff
(98.4 %id)
BQ340511 nervous_normal .m 79 to 445 1 to 365       365/365
(100 %)
4 diff
(99.0 %id)
BE280480 choriocarcinoma, placenta .m 80 to 566 1 to 487   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
BM702796 eye, Retina Foveal and Macular .m 80 to 565 14 to 500       487/500
(97 %)
6 diff
(98.8 %id)
BG108717 retina, Retinal Pigment Epithelium sheets .m 81 to 415 1 to 333       333/333
(100 %)
5 diff
(98.5 %id)
BQ340343 nervous_normal .m 81 to 445 1 to 365       365/365
(100 %)
2 diff
(99.5 %id)
AA745280 Ewing's sarcoma .m 81 to 509 1 to 426       426/426
(100 %)
8 diff
(98.2 %id)
BM452435 eye, retinoblastoma .m 81 to 566 1 to 486   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 486/486
(100 %)
0 diff
(100 %id)
BQ880298 epidermoid carcinoma, cell line, salivary gland .m 82 to 566 1 to 485   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
DB572386 hypothalamus .m 83 to 565 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
AA308774 colon .m 84 to 571 1 to 489       489/489
(100 %)
3 diff
(99.4 %id)
W76640 heart .m 84 to 324 1 to 241   fully sequenced,   241/241
(100 %)
5 diff
(98.0 %id)
W79713 heart .m 84 to 351 1 to 267   fully sequenced,   267/267
(100 %)
9 diff
(96.7 %id)
BG112117 Bone, osteosarcoma, cell line .m 84 to 565 1 to 483       483/504
(95 %)
5 diff
(99.1 %id)
AF085906   .m 85 to 571 1 to 487   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
BY800217 eye .m 86 to 565 11 to 490       480/491
(97 %)
7 diff
(98.6 %id)
CB158352 Liver .m 86 to 565 1 to 480   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 480/480
(100 %)
1 diff
(99.8 %id)
BE256643 eye, retinoblastoma .m 88 to 566 1 to 479   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 479/479
(100 %)
0 diff
(100 %id)
AA707907 pineal gland .m 89 to 565 478 to 1       478/478
(100 %)
7 diff
(98.6 %id)
AI022229 liver and spleen .m 89 to 568 482 to 3       480/482
(99 %)
1 diff
(99.8 %id)
AI041107   .m 92 to 568 481 to 6       476/484
(98 %)
1 diff
(99.8 %id)
BU507446 leiomyosarcoma, uterus .m 92 to 567 1 to 476       476/476
(100 %)
0 diff
(100 %id)
BU853445 testis .m 92 to 568 1 to 477       477/509
(93 %)
4 diff
(99.3 %id)
DB544129 hippocampus .m 93 to 566 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
BE855958 Prostate .m 94 to 568 479 to 3       477/479
(99 %)
3 diff
(99.4 %id)
BG338194 leiomyosarcoma cell line, uterus .m 96 to 566 1 to 471   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 471/471
(100 %)
1 diff
(99.8 %id)
AA740169 2 pooled tumors (clear cell type), Kidney .m 98 to 568 476 to 8       469/476
(98 %)
4 diff
(99.2 %id)
AA315816 colon .m 99 to 571 1 to 473       473/474
(99 %)
1 diff
(99.8 %id)
N41413 placenta .m 99 to 566 1 to 466   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 466/466
(100 %)
5 diff
(99.0 %id)
AA598700 lung, lung carcinoma .m 99 to 565 466 to 2       465/466
(99 %)
4 diff
(99.2 %id)
BE386254 melanotic melanoma, skin .m 99 to 564 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
AV753001 Pituitary .m 99 to 566 1 to 468   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 468/468
(100 %)
3 diff
(99.4 %id)
F25684 pectoral muscle (after mastectomy) .m 100 to 472 1 to 373       373/373
(100 %)
0 diff
(100 %id)
AY099360 whole brain .m 103 to 408 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
BF822476 kidney_tumor .m 104 to 508 408 to 3     Submitted on the opposite strand 406/423
(95 %)
8 diff
(98.2 %id)
AI266102 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 106 to 568 464 to 1       464/467
(99 %)
9 diff
(98.1 %id)
AA701641 liver and spleen .m 107 to 566 458 to 1       458/458
(100 %)
4 diff
(99.2 %id)
BE407935 choriocarcinoma, placenta .m 107 to 565 1 to 459   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
AA991432 pooled germ cell tumors .m 108 to 518 410 to 1       410/410
(100 %)
3 diff
(99.3 %id)
DB564831 hypothalamus .m 109 to 565 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
BG054985 brain, glioblastoma (pooled) .m 112 to 566 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AA704484 liver and spleen .m 114 to 565 450 to 1       450/450
(100 %)
6 diff
(98.7 %id)
BF747781 breast .m 115 to 385 324 to 57     Submitted on the opposite strand 267/324
(82 %)
8 diff
(97.6 %id)
CN305896 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 115 to 258 1 to 144       144/144
(100 %)
0 diff
(100 %id)
BU927779 mixed (pool of 40 RNAs) .m 117 to 568 1 to 452       452/458
(98 %)
2 diff
(99.6 %id)
AA722697 heart .m 120 to 568 451 to 5       447/451
(99 %)
4 diff
(99.2 %id)
AA699317 liver and spleen .m 120 to 566 445 to 1       445/445
(100 %)
6 diff
(98.7 %id)
AA977173 pooled germ cell tumors .m 120 to 566 456 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 446/446
(100 %)
5 diff
(98.9 %id)
AI129338 uterus .m 120 to 565 458 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 446/446
(100 %)
4 diff
(99.2 %id)
AI190633 heart .m 120 to 566 457 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 447/447
(100 %)
1 diff
(99.8 %id)
AI299232 2 pooled tumors (clear cell type), Kidney .m 120 to 566 457 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 447/447
(100 %)
2 diff
(99.6 %id)
AI310807 2 pooled tumors (clear cell type), Kidney .m 120 to 321 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AI363131 anaplastic oligodendroglioma, brain .m 120 to 568 455 to 7       449/455
(98 %)
1 diff
(99.8 %id)
AI343871 2 pooled tumors (clear cell type), Kidney .m 123 to 566 457 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 444/444
(100 %)
0 diff
(100 %id)
AI355668 lung .m 123 to 568 449 to 4       446/452
(98 %)
2 diff
(99.6 %id)
AI494283 anaplastic oligodendroglioma, brain .m 123 to 568 453 to 8       446/453
(98 %)
0 diff
(100 %id)
AW005664 anaplastic oligodendroglioma, brain .m 125 to 568 452 to 9       444/452
(98 %)
0 diff
(100 %id)
AW117478 pooled .m 125 to 566 454 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
AI709080 aorta .m 131 to 568 439 to 2       438/439
(99 %)
0 diff
(100 %id)
AW239094 lung, cell line .m 132 to 601 1 to 470       470/470
(100 %)
0 diff
(100 %id)
D54718   .m 137 to 565 425 to 1       425/425
(100 %)
8 diff
(98.2 %id)
BG214137   .m 141 to 565 1 to 426   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 426/426
(100 %)
3 diff
(99.3 %id)
AA770648 carcinoid, lung .m 142 to 566 437 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 423/448
(94 %)
4 diff
(99.2 %id)
AA947950 carcinoid, lung .m 142 to 563 420 to 1       420/423
(99 %)
4 diff
(99.1 %id)
AA533144 normal prostatic epithelial cells, Prostate .m 144 to 563 419 to 1       419/460
(91 %)
5 diff
(99.0 %id)
BM548550 brain, hippocampus .m 145 to 1103 10 to 979   tiling clone,   970/1120
(86 %)
41 diff
(96.4 %id)
AI299979 carcinoid, lung .m 150 to 566 432 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 417/417
(100 %)
1 diff
(99.8 %id)
CF128690 Chondrosarcoma Lung Metastasis cell lines, lung .m 150 to 565 1 to 415   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 415/415
(100 %)
1 diff
(99.8 %id)
BF791890 adrenal cortex carcinoma, cell line, adrenal gland .m 153 to 565 1 to 409   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 409/409
(100 %)
5 diff
(98.8 %id)
AA884817 pooled .m 159 to 566 407 to 1       407/410
(99 %)
1 diff
(99.8 %id)
AA808457 germinal center B cell .m 165 to 566 420 to 20   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 401/401
(100 %)
3 diff
(99.3 %id)
AI084918 anaplastic oligodendroglioma, brain .m 165 to 568 404 to 1       404/404
(100 %)
1 diff
(99.8 %id)
BU162440 melanotic melanoma, cell line, skin .m 169 to 566 1 to 398   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 398/398
(100 %)
1 diff
(99.8 %id)
AA114924 uterus .m 171 to 748 35 to 623       589/623
(94 %)
22 diff
(96.5 %id)
AI128584 heart .m 174 to 565 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
BG491397 amelanotic melanoma, cell line, skin .m 186 to 565 1 to 378   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 378/378
(100 %)
2 diff
(99.5 %id)
BM911843 amelanotic melanoma, cell line, skin .m 188 to 566 1 to 379   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
BM743496 Ascites, stomach .m 190 to 566 1 to 376   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 376/376
(100 %)
2 diff
(99.5 %id)
D52875   .m 192 to 565 372 to 1   fully sequenced,   372/372
(100 %)
5 diff
(98.7 %id)
BM670693 eye, fetal eyes .m 192 to 566 393 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
BE382489 brain, neuroblastoma .m 196 to 565 1 to 370       370/372
(99 %)
2 diff
(99.5 %id)
CF129209 Chondrosarcoma Lung Metastasis cell lines, lung .m 201 to 566 1 to 366   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 366/366
(100 %)
4 diff
(99.0 %id)
BY998907   .m 216 to 568 1 to 353     Submitted on the opposite strand 353/354
(99 %)
1 diff
(99.8 %id)
BY998979   .m 216 to 568 1 to 353     Submitted on the opposite strand 353/354
(99 %)
1 diff
(99.8 %id)
BG219881   .m 224 to 553 379 to 51   AAA Submitted on the opposite strand 329/347
(94 %)
5 diff
(98.6 %id)
AA724428 pooled .m 224 to 568 345 to 2       344/345
(99 %)
1 diff
(99.8 %id)
F37949 pectoral muscle (after mastectomy) .m 234 to 565 1 to 332       332/332
(100 %)
5 diff
(98.5 %id)
AA491586 Ewing's sarcoma .m 241 to 566 344 to 20   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 325/325
(100 %)
1 diff
(99.7 %id)
AA658037   .m 261 to 351 91 to 1       91/91
(100 %)
0 diff
(100 %id)
W73052 heart .m 263 to 567 305 to 1   fully sequenced,   305/305
(100 %)
0 diff
(100 %id)
CN305891 embryonic stem cells, DMSO-treated H9 cellline .m 278 to 577 1 to 300   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 300/300
(100 %)
0 diff
(100 %id)
AA524092 colon .m 291 to 565 275 to 1       275/275
(100 %)
0 diff
(100 %id)
BG212546   .m 292 to 577 1 to 284       284/284
(100 %)
5 diff
(98.3 %id)
GD158296   .m 294 to 566 1 to 273   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 273/273
(100 %)
2 diff
(99.3 %id)
BG217323   .m 296 to 571 1 to 275   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 275/275
(100 %)
3 diff
(99.0 %id)
CN305895 embryonic stem cells, DMSO-treated H9 cellline .m 297 to 568 1 to 272       272/277
(98 %)
2 diff
(99.3 %id)
AA852096 Bone, Hip .m 299 to 554 266 to 8       259/300
(86 %)
3 diff
(99.0 %id)
FN054821 breast carcinoma .m 313 to 414 102 to 1     Submitted on the opposite strand 102/102
(100 %)
0 diff
(100 %id)
AA632937 breast .m 318 to 559 247 to 6       242/247
(97 %)
0 diff
(100 %id)
W81385 heart .m 321 to 565 246 to 1   fully sequenced,   246/246
(100 %)
0 diff
(100 %id)
AA513190 Ewing's sarcoma .m 323 to 565 1 to 242   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 242/242
(100 %)
5 diff
(98.0 %id)
DN602016 human embryonic stem cells .m 336 to 919 1 to 584   tiling clone,   584/584
(100 %)
0 diff
(100 %id)
AA700360 liver and spleen .m 348 to 566 219 to 1       219/219
(100 %)
1 diff
(99.6 %id)
BM667060 eye, fetal eyes .m 435 to 566 150 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 132/132
(100 %)
0 diff
(100 %id)
CD675493 eye, lens .m 460 to 566 1 to 107   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 107/107
(100 %)
0 diff
(100 %id)
AA678104 liver and spleen .m 992 to 1433 441 to 1   tiling clone,   441/441
(100 %)
2 diff
(99.6 %id)
BF739981 Kidney .m 1094 to 1427 335 to 2       334/335
(99 %)
0 diff
(100 %id)
BU584599 stomach .m 1190 to 1631 445 to 1   tiling clone,   445/445
(100 %)
5 diff
(98.9 %id)
AA378419 synovial membrane .n-u 1 to 341 1 to 343 exact tiling clone,   343/343
(100 %)
4 diff
(98.9 %id)
DA353856 substantia nigra .o 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BF961154 nervous_normal .o 7 to 262 268 to 14       255/277
(92 %)
9 diff
(96.8 %id)
BF962530 nervous_normal .o 7 to 262 289 to 34       256/298
(85 %)
8 diff
(97.4 %id)
DA186212 amygdala .o 35 to 556 2 to 523 exact tiling clone, capped   522/522
(100 %)
0 diff
(100 %id)
BP273012   .p 1 to 443 1 to 443 A3L D6Y tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 443/443
(100 %)
4 diff
(99.1 %id)
AA721776 Ewing's sarcoma .q 1 to 338 1 to 337 H2D W17C P79Q tiling clone,   337/344
(97 %)
11 diff
(96.9 %id)
AI140018 heart .r 1 to 375 376 to 2 exact tiling clone,   375/376
(99 %)
0 diff
(100 %id)
DW418401 Liver .s 1 to 375 10 to 384 T9A tiling clone,   375/428
(87 %)
12 diff
(97.2 %id)
DA293422 hippocampus .t 1 to 458 2 to 461   tiling clone, capped   460/460
(100 %)
3 diff
(99.4 %id)
DA840551 placenta .t 1 to 441 2 to 442   tiling clone, capped   441/441
(100 %)
1 diff
(99.8 %id)
BG326674 Kidney, renal cell adenocarcinoma .t 39 to 1267 32 to 637   AAA   530/646
(82 %)
39 diff
(94.0 %id)
BU661207 blood .t 404 to 1083 1 to 679   tiling clone,   679/679
(100 %)
5 diff
(99.3 %id)
FN071607 breast carcinoma .t 432 to 494 62 to 1     Submitted on the opposite strand 62/64
(96 %)
1 diff
(98.5 %id)
DB504402 hypothalamus .u 1 to 484 1 to 484 exact tiling clone,   484/484
(100 %)
1 diff
(99.8 %id)
DB575644 hypothalamus .u 2 to 489 7 to 495 exact tiling clone, Submitted on the opposite strand 489/497
(98 %)
7 diff
(98.6 %id)
BF747003 breast .u 28 to 449 434 to 13 Q55P   Submitted on the opposite strand 422/434
(97 %)
2 diff
(99.6 %id)
CF124893 CNCAP(3)T-225 cell line, Prostate .va 1 to 309 287 to 595 exact     309/595
(51 %)
6 diff
(99.0 %id)
TI_154185291   .va 1 to 369 349 to 716 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 368/647
(56 %)
9 diff
(98.7 %id)
BE866592 bladder, carcinoma, cell line .vb-u 1 to 564 1 to 568 C30R G41A F42L R43D C44A ... tiling clone,   568/812
(69 %)
18 diff
(97.8 %id)
DA835273 placenta .vb-u 72 to 622 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AK057119 Spleen .vb-u 315 to 2267 1 to 1953   tiling clone, available from FLJ,   1953/1953
(100 %)
1 diff
(100.0 %id)
DA931232 Spleen .vb-u 316 to 1184 2 to 866   capped   865/867
(99 %)
15 diff
(98.3 %id)
BX093383 melanocyte .vb-u 812 to 1553 1 to 743       743/743
(100 %)
1 diff
(99.9 %id)
CN430726 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vb-u 1080 to 1706 1 to 628   tiling clone,   628/628
(100 %)
3 diff
(99.6 %id)
BC062446 Skin and meninges pool- skin, dura matter,pia matter, choroid plexus. .vb-u 1185 to 1828 1 to 644   available from MGC, AAA   644/644
(100 %)
3 diff
(99.6 %id)
CB998995 Pooled-Skin .vb-u 1186 to 1824 1 to 643   available from MGC, AAA   643/879
(73 %)
7 diff
(99.3 %id)
EL952917 eyeball .vb-u 1200 to 1659 51 to 510       460/510
(90 %)
8 diff
(98.5 %id)
BG946615 bladder_tumor .vb-u 1342 to 1705 25 to 386       362/389
(93 %)
11 diff
(97.2 %id)
BM687849 eye, Retina Foveal and Macular .vb-u 1360 to 1722 6 to 368       363/368
(98 %)
6 diff
(98.4 %id)
AI042495 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vb-u 1381 to 1839 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AI123248 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vb-u 1381 to 1837 458 to 1       458/458
(100 %)
2 diff
(99.6 %id)
N21682 melanocyte .vb-u 1384 to 1839 463 to 1       463/463
(100 %)
10 diff
(97.9 %id)
AI042496 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vb-u 1415 to 1839 425 to 1       425/425
(100 %)
3 diff
(99.3 %id)
AI377541 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vb-u 1443 to 1837 395 to 1       395/395
(100 %)
0 diff
(100 %id)
DB332431 Spleen .vb-u 1822 to 2267 450 to 1       450/450
(100 %)
11 diff
(97.6 %id)
BI667312 brain, hypothalamus .vb-u 1834 to 2267 1 to 434   available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 434/434
(100 %)
5 diff
(98.9 %id)
DB560843 hypothalamus .vb-u 1839 to 2267 15 to 445     Submitted on the opposite strand 431/445
(96 %)
6 diff
(98.7 %id)
TI_44343662   .vb-u 1839 to 2267 88 to 516   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 429/516
(83 %)
6 diff
(98.9 %id)
BC039451 Brain, hypothalamus .vb-u 1848 to 2267 10 to 429   available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
AK090764 alzheimer cortex .vc 1 to 1870 2 to 1871 exact tiling clone, available from FLJ,   1871/1871
(100 %)
3 diff
(99.9 %id)
DA129393 alzheimer cortex .vc 1 to 420 2 to 421   capped   420/420
(100 %)
0 diff
(100 %id)
BG913893 anaplastic oligodendroglioma with 1p/19qloss, brain .vc 84 to 814 12 to 753       742/818
(90 %)
6 diff
(99.3 %id)
BG960563 colon .vc 166 to 529 364 to 2       363/364
(99 %)
0 diff
(100 %id)
AL601629   .vc 207 to 622 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
BF356652 head_neck .vc 235 to 541 1 to 306       306/313
(97 %)
5 diff
(98.5 %id)
BF356650 head_neck .vc 237 to 541 1 to 305       305/310
(98 %)
3 diff
(99.1 %id)
AL599586   .vc 244 to 533 1 to 290       290/290
(100 %)
5 diff
(98.3 %id)
BF352442 head_neck .vc 263 to 648 401 to 16       386/401
(96 %)
0 diff
(100 %id)
DA080878 cerebellum .vc 317 to 886 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
FN141504 breast carcinoma .vc 332 to 385 1 to 55       55/56
(98 %)
2 diff
(96.5 %id)
BE168679 head_neck .vc 366 to 526 6 to 164       159/164
(96 %)
7 diff
(95.8 %id)
BX954261   .vc 373 to 977 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
CD519114 White Matter .vc 421 to 1189 1 to 779       779/885
(88 %)
12 diff
(98.7 %id)
CR747885 Kidney .vc 698 to 1317 1 to 621   tiling clone,   621/621
(100 %)
1 diff
(99.9 %id)
BF368286 placenta_normal .vc 730 to 909 1 to 179       179/179
(100 %)
10 diff
(94.5 %id)
BG001820 placenta_normal .vc 734 to 909 20 to 194       175/194
(90 %)
6 diff
(97.0 %id)
BQ321413 colon .vc 735 to 830 10 to 104       95/104
(91 %)
6 diff
(94.3 %id)
BQ376278 testis_normal .vc 740 to 914 17 to 190       174/204
(85 %)
14 diff
(93.2 %id)
BF368284 placenta_normal .vc 744 to 924 192 to 13       180/192
(93 %)
0 diff
(100 %id)
BF376646 testis_normal .vc 744 to 886 149 to 7       143/149
(95 %)
0 diff
(100 %id)
BG001812 placenta_normal .vc 744 to 907 165 to 3       163/165
(98 %)
0 diff
(100 %id)
BG001819 placenta_normal .vc 744 to 909 167 to 1       167/167
(100 %)
3 diff
(98.3 %id)
EH326758   .vc 768 to 837 1 to 69       69/69
(100 %)
1 diff
(98.6 %id)
TI_57167357   .vc 820 to 1517 32 to 730       699/730
(95 %)
6 diff
(99.2 %id)
BI835262 pooled pancreas and spleen .vc 821 to 1517 1 to 698       698/698
(100 %)
3 diff
(99.6 %id)
BF354042 head_neck .vc 938 to 1148 1 to 211       211/220
(95 %)
6 diff
(97.3 %id)
AW179324 stomach .vc 1251 to 1749 504 to 2 F2V S3F S5Q M6L L7C ...     503/504
(99 %)
13 diff
(97.5 %id)
BQ640607 eye, retina .vc 1276 to 1841 1 to 569 exact     569/569
(100 %)
4 diff
(99.3 %id)
AA663765 schizophrenic brain S-11 frontal lobe .vc 1306 to 1686 1 to 381     Submitted on the opposite strand 381/388
(98 %)
4 diff
(99.0 %id)
AA932194 Kidney .vc 1409 to 1872 467 to 5 exact tiling clone,   463/467
(99 %)
1 diff
(99.8 %id)
DB301007 alzheimer cortex .vc 1419 to 1870 452 to 1 C22X     452/452
(100 %)
1 diff
(99.8 %id)
AI002307 carcinoid, lung .vc 1446 to 1870 448 to 25 V23S H24I W25G T26Q T27Q ... AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 424/424
(100 %)
3 diff
(99.3 %id)
TI_1242414576   .vd-u 1 to 1073 59 to 1126 exact tiling clone,   1068/1198
(89 %)
6 diff
(99.5 %id)
TI_1242418488   .vd-u 1 to 964 62 to 1024 exact     963/1024
(94 %)
6 diff
(99.5 %id)
BM697797 eye, fetal eyes .vd-u 343 to 840 1 to 498 exact     498/498
(100 %)
0 diff
(100 %id)
BU736087 eye, fetal eyes .vd-u 1222 to 1767 564 to 19   tiling clone, AAA   546/546
(100 %)
0 diff
(100 %id)
AA703189 liver and spleen .vd-u 1271 to 1756 488 to 3       486/488
(99 %)
0 diff
(100 %id)
BX108020 placenta .vd-u 1272 to 1756 1 to 485   AAA   485/485
(100 %)
0 diff
(100 %id)
R22532 placenta .vd-u 1272 to 1511 1 to 239   fully sequenced,   239/239
(100 %)
1 diff
(99.6 %id)
AI808289 pooled .vd-u 1284 to 1735 493 to 43   AAA   451/479
(94 %)
0 diff
(100 %id)
AI911219 pooled .vd-u 1305 to 1756 453 to 2       452/453
(99 %)
0 diff
(100 %id)
AI635379 pooled germ cell tumors .vd-u 1313 to 1768 456 to 1       456/703
(64 %)
0 diff
(100 %id)
AW043558 pooled .vd-u 1315 to 1756 443 to 2       442/443
(99 %)
0 diff
(100 %id)
AW389519 stomach .vd-u 1326 to 1723 417 to 20       398/417
(95 %)
0 diff
(100 %id)
AA603979 Prostate, prostate tumor .vd-u 1340 to 1756 419 to 3       417/419
(99 %)
0 diff
(100 %id)
AA865115 germinal center B cell .vd-u 1412 to 1763 374 to 23   AAA   352/352
(100 %)
0 diff
(100 %id)
R09760 liver and spleen .vd-u 1413 to 1756 354 to 5       350/432
(81 %)
0 diff
(100 %id)
AW173088 pooled .vd-u 1424 to 1763 354 to 15   AAA   340/340
(100 %)
2 diff
(99.5 %id)
AI620801 Prostate .vd-u 1426 to 1768 346 to 4       343/346
(99 %)
0 diff
(100 %id)
R22533 placenta .vd-u 1481 to 1757 281 to 1   fully sequenced,   281/281
(100 %)
7 diff
(97.6 %id)
BM980889 lung, Primary Lung Cystic Fibrosis EpithelialCells .vd-u 1608 to 1776 187 to 19   tiling clone, AAA   169/169
(100 %)
0 diff
(100 %id)
DB458220.
matches multiple genes
testis .ve 1 to 479 3 to 481 exact tiling clone, also hits gene karee 481/481
(100 %)
2 diff
(99.6 %id)
BG719958 testis .ve 8 to 784 1 to 779       779/779
(100 %)
7 diff
(99.2 %id)
BC005331 Brain, primitive neuroectodermal .ve 14 to 1432 1 to 1419   tiling clone, available from MGC, AAA   1419/1419
(100 %)
3 diff
(99.8 %id)
BE958533 brain, primitive neuroectoderm .ve 33 to 719 1 to 693   available from MGC,   693/711
(97 %)
26 diff
(96.4 %id)
BF978458 melanotic melanoma, high MDR, skin .ve 33 to 755 1 to 717       717/890
(80 %)
14 diff
(98.5 %id)
BG494911 lung, mucoepidermoid carcinoma .ve 33 to 704 1 to 673       673/673
(100 %)
3 diff
(99.6 %id)
BF029378 bladder, carcinoma, cell line .ve 42 to 588 1 to 566       562/618
(90 %)
36 diff
(94.2 %id)
BG686505 B-cells, primary B-cells from tonsils (cell line) .ve 63 to 702 1 to 640   available from MGC,   640/642
(99 %)
2 diff
(99.7 %id)
BC023654 Primary B-Cells from Tonsils .ve 64 to 1428 1 to 1365   available from MGC, AAA   1365/1365
(100 %)
1 diff
(100.0 %id)
BU193581 melanotic melanoma, skin .ve 72 to 929 8 to 872   available from MGC,   865/888
(97 %)
21 diff
(97.7 %id)
R09949 liver and spleen .ve 75 to 430 1 to 372       372/372
(100 %)
25 diff
(93.3 %id)
BF795813 lymph, lymphoma, cell line .ve 75 to 780 12 to 713       702/935
(75 %)
21 diff
(97.8 %id)
BC053556 Skin, melanotic melanoma. .ve 76 to 1421 1 to 1346   available from MGC, AAA   1346/1346
(100 %)
0 diff
(100 %id)
BU165976 melanotic melanoma, skin .ve 78 to 819 12 to 760       749/921
(81 %)
16 diff
(98.3 %id)
BC011632 Skin, melanotic melanoma. .ve 84 to 1421 1 to 1338   available from MGC, AAA   1338/1338
(100 %)
0 diff
(100 %id)
CX752385 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .ve 93 to 782 1 to 690     Submitted on the opposite strand 690/690
(100 %)
0 diff
(100 %id)
CN257896 embryonic stem cells, DMSO-treated H9 cellline .ve 100 to 848 1 to 750       750/750
(100 %)
4 diff
(99.5 %id)
BF125817 melanotic melanoma, skin .ve 104 to 786 1 to 682   available from MGC,   682/917
(74 %)
15 diff
(98.4 %id)
BQ434316 melanotic melanoma, skin .ve 117 to 998 5 to 888       884/888
(99 %)
15 diff
(98.4 %id)
CN257900 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .ve 119 to 719 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BF724265 eye, Iris .ve 309 to 697 1 to 389       389/389
(100 %)
4 diff
(99.0 %id)
CN257898 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .ve 337 to 944 1 to 610       610/610
(100 %)
5 diff
(99.2 %id)
R12589 liver and spleen .ve 677 to 984 318 to 5       314/372
(84 %)
0 diff
(100 %id)
BU628809 Bone, Enchondroma cell line .ve 687 to 1432 763 to 19   AAA   745/745
(100 %)
4 diff
(99.5 %id)
CA425939 cell lines, Chondrosarcoma .ve 735 to 1421 705 to 19   AAA   687/687
(100 %)
1 diff
(99.9 %id)
BU628165 Bone, Enchondroma cell line .ve 774 to 1432 677 to 19   AAA   659/659
(100 %)
3 diff
(99.6 %id)
FN106893 breast carcinoma .ve 790 to 874 1 to 85       85/85
(100 %)
0 diff
(100 %id)
TI_59393552   .ve 814 to 1431 46 to 662   AAA   617/617
(100 %)
7 diff
(98.9 %id)
BM015322 breast, mammary adenocarcinoma, cell line .ve 815 to 1431 1 to 616   AAA   616/616
(100 %)
7 diff
(98.9 %id)
DA355646 subthalamic nucleus .vf 1 to 558 2 to 560 S24F W25L T26D I27D tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
CD236983 Pituitary .vf 2 to 692 1 to 691 exact     691/691
(100 %)
1 diff
(99.9 %id)
AX721172   .vf 15 to 1302 1 to 1286 exact tiling clone,   1286/1286
(100 %)
3 diff
(99.8 %id)
BC045166 Breast, mammary adenocarcinoma. .vf 50 to 354 1 to 305 exact available from MGC, AAA   305/305
(100 %)
0 diff
(100 %id)
TI_59394567   .vf 50 to 354 90 to 394 exact AAA   305/305
(100 %)
0 diff
(100 %id)
BM016174 breast, mammary adenocarcinoma, cell line .vf 51 to 354 1 to 304 exact available from MGC, AAA   304/304
(100 %)
0 diff
(100 %id)
BU159127 eye, retinoblastoma .vf 57 to 606 1 to 559 exact     559/784
(71 %)
25 diff
(96.9 %id)
DB310473 subthalamic nucleus .vf 788 to 1301 514 to 1   tiling clone,   514/514
(100 %)
2 diff
(99.7 %id)
BU169268 epidermoid carcinoma, cell line, salivary gland .vg 1 to 771 1 to 771 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 771/771
(100 %)
0 diff
(100 %id)
BU169264 epidermoid carcinoma, cell line, salivary gland .vg 3 to 771 34 to 803 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 770/804
(95 %)
10 diff
(98.8 %id)
CN364892 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vh 1 to 702 1 to 702 exact tiling clone,   702/702
(100 %)
1 diff
(99.9 %id)
DA295533 hippocampus .vi-u 1 to 564 2 to 564 exact tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
DA776145 brain .vi-u 136 to 699 2 to 565 exact tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
CK004424 brain/CNS, Human Brain - Frontal Cortex .vj 1 to 601 1 to 600 exact tiling clone,   600/601
(99 %)
5 diff
(99.2 %id)
DA094429 cerebellum .vj 10 to 564 2 to 557 C42X A43C I44H C45L R46Q ... capped   556/556
(100 %)
2 diff
(99.7 %id)
DA370082 subthalamic nucleus .vj 10 to 565 2 to 557 exact capped   556/556
(100 %)
2 diff
(99.7 %id)
BI223624 cervical carcinoma cell line, cervix .vj 11 to 678 1 to 670 S11E G12R T13H N14Q S15Q ...     670/730
(91 %)
12 diff
(98.4 %id)
AI814515 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .vj 98 to 682 597 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 585/589
(99 %)
2 diff
(99.7 %id)
AA812938   .vj 229 to 684 462 to 8       455/462
(98 %)
2 diff
(99.6 %id)
AA852095 Bone, Hip .vj 236 to 531 9 to 303       295/303
(97 %)
3 diff
(99.1 %id)
BF512968   .vj 249 to 687 456 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 439/439
(100 %)
0 diff
(100 %id)
BF918069 uterus_tumor .vk-u 1 to 197 1 to 197   tiling clone,   197/197
(100 %)
4 diff
(98.0 %id)
AI860168 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .vk-u 146 to 607 463 to 1   tiling clone,   463/463
(100 %)
10 diff
(97.9 %id)
DA352140 substantia nigra .vl 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
TI_57164904   .vm 1 to 446 34 to 480 H19Q tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 447/480
(93 %)
9 diff
(98.2 %id)
AW161517 brain, frontal lobe .vm 7 to 446 1 to 440 exact tiling clone,   440/442
(99 %)
1 diff
(99.8 %id)
AW161957 brain, frontal lobe .vm 7 to 425 1 to 419 exact     419/419
(100 %)
0 diff
(100 %id)
AW163628 brain, frontal lobe .vm 7 to 442 1 to 436 exact     436/436
(100 %)
0 diff
(100 %id)
AA843156 parathyroid gland, parathyroid tumor .vm 56 to 449 398 to 6 exact     393/398
(98 %)
1 diff
(99.8 %id)
AA570209   .vn-u 1 to 387 1 to 385 I2T S7G tiling clone,   385/387
(99 %)
6 diff
(98.5 %id)
BX648018 human retina Gene XPNPEP3andRBX1, variant not shown       available from DKFZ, AAA This clone was ignored    
AW177678 colon Gene XPNPEP3andRBX1, variant not shown         This clone was ignored    
BC032537.
matches multiple genes
Skin, melanotic melanoma. Gene XPNPEP3andRBX1, variant not shown       available from MGC, AAA This clone was ignored, also hits gene lorga    
BC032537.
matches multiple genes
Skin, melanotic melanoma. Gene lorga, variant not shown       available from MGC, AAA This clone was ignored, also hits gene lorga    
155 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l, .m, .n-u, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u, .vc, .vd-u, .ve, .vf, .vg, .vh, .vi-u, .vj, .vk-u, .vl, .vm, .vn-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI